This follows companies successfully developing the formulations
Favipiravir and Remdesivir, the drugs, which along with dexamethasone
have been included in the Covid-19 clinical management protocol in
Southeast Asia, Eastern Europe and Gulf Cooperation Council region.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/local-covid-drug-makers-ramp-up-capacity/articleshow/76518954.cms
No comments:
Post a Comment